IQAIF (Imaging Biometrics) Beneish M-Score: -4.75 (As of Jun. 26, 2026)

What is Imaging Biometrics Beneish M-Score?

Imaging Biometrics IQAIF Beneish M-Score is -4.75 as of Jun. 26, 2026. The stock has 3 warning signs investors should review. Among 633 Healthcare Providers & Services companies, Imaging Biometrics ranks better than 95.26% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -4.75 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Imaging Biometrics's Beneish M-Score or its related term are showing as below:

IQAIF' s Beneish M-Score Range Over the Past 10 Years
Min: -6.32 Med: -3.01 Max: -1.19
Current: -4.75

During the past 13 years, the highest Beneish M-Score of Imaging Biometrics was -1.19. The lowest was -6.32. And the median was -3.01.

Imaging Biometrics Beneish M-Score Related Terms

Imaging Biometrics Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Imaging Biometrics's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imaging Biometrics Beneish M-Score Chart

Imaging Biometrics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Beneish M-Score

Get a 7-Day Free Trial

-2.48

-1.19

-6.32

-3.07

-4.75

Imaging Biometrics Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Beneish M-Score	Get a 7-Day Free Trial															-6.32	0.00	-3.07	0.00	-4.75

IQAIF vs VEEV, BTSG, TEM: Beneish M-Score Comparison

For the Health Information Services subindustry, Imaging Biometrics's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Imaging Biometrics Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Imaging Biometrics's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Imaging Biometrics's Beneish M-Score falls into.

Save Embed

Imaging Biometrics Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Imaging Biometrics for today is based on a combination of the following eight different indices:

-4.84

0.92 * DSRI

0.528 * GMI

0.404 * AQI

0.892 * SGI

0.115 * DEPI

-4.84

0.92 * 0.7868

0.528 * 1.0576

0.404 * 0.9171

0.892 * 1.1129

0.115 * 0.9936

0.172 * SGAI

4.679 * TATA

0.327 * LVGI

0.172 * 0.795

4.679 * -0.468681

0.327 * 0.8885

-4.70

This Year (Dec25) TTM:

Last Year (Dec24) TTM:

Total Receivables was $0.18 Mil.
Revenue was $1.06 Mil.
Gross Profit was $0.99 Mil.
Total Current Assets was $0.45 Mil.
Total Assets was $1.36 Mil.
Property, Plant and Equipment(Net PPE) was $0.00 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.12 Mil.
Selling, General, & Admin. Expense(SGA) was $1.20 Mil.
Total Current Liabilities was $0.81 Mil.
Long-Term Debt & Capital Lease Obligation was $0.00 Mil.
Net Income was $-0.54 Mil.
Gross Profit was $0.00 Mil.
Cash Flow from Operations was $0.10 Mil.

Total Receivables was $0.21 Mil.
Revenue was $0.95 Mil.
Gross Profit was $0.94 Mil.
Total Current Assets was $0.32 Mil.
Total Assets was $1.18 Mil.
Property, Plant and Equipment(Net PPE) was $0.00 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.07 Mil.
Selling, General, & Admin. Expense(SGA) was $1.35 Mil.
Total Current Liabilities was $0.79 Mil.
Long-Term Debt & Capital Lease Obligation was $0.00 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI	=	(Receivables_t / Revenue_t)	/	(Receivables_t-1 / Revenue_t-1)
	=	(0.183 / 1.055)	/	(0.209 / 0.948)
	=	0.17346	/	0.220464
	=	0.7868

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI	=	GrossMargin_t-1	/	GrossMargin_t
	=	(GrossProfit_t-1 / Revenue_t-1)	/	(GrossProfit_t / Revenue_t)
	=	(0.938 / 0.948)	/	(0.987 / 1.055)
	=	0.989451	/	0.935545
	=	1.0576

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI	=	(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t)	/	(1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
	=	(1 - (0.448 + 0.001) / 1.357)	/	(1 - (0.317 + 0.001) / 1.176)
	=	0.669123	/	0.729592
	=	0.9171

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI	=	Sales_t	/	Sales_t-1
	=	Revenue_t	/	Revenue_t-1
	=	1.055	/	0.948
	=	1.1129

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI	=	(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))	/	(Depreciation_t / (Depreciaton_t + PPE_t))
	=	(0.068 / (0.068 + 0.001))	/	(0.122 / (0.122 + 0.001))
	=	0.985507	/	0.99187
	=	0.9936

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI	=	(SGA_t / Sales_t)	/	(SGA_t-1 /Sales_t-1)
	=	(1.197 / 1.055)	/	(1.353 / 0.948)
	=	1.134597	/	1.427215
	=	0.795

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI	=	((LTD_t + CurrentLiabilities_t) / TotalAssets_t)	/	((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
	=	((0 + 0.813) / 1.357)	/	((0 + 0.793) / 1.176)
	=	0.599116	/	0.67432
	=	0.8885

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA	=	(IncomefromContinuingOperations_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(NetIncome_t - NonOperatingIncome_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(-0.537 - 0	-	0.099)	/	1.357
	=	-0.468681

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Imaging Biometrics has a M-score of -4.70 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →

What does a Beneish M-Score of -4.75 mean?

Imaging Biometrics (IQAIF) has a Beneish M-Score of -4.75 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Imaging Biometrics and its competitors. According to the industry distribution chart, Imaging Biometrics ranks #30 out of 633 companies in the Healthcare Providers & Services industry, placing it in the top 4.7%.

Is Imaging Biometrics' Beneish M-Score too high?

Imaging Biometrics' current Beneish M-Score is -4.75. Based on the distribution chart, Imaging Biometrics ranks #30 out of 633 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers.

How does Imaging Biometrics' Beneish M-Score compare to VEEV and BTSG?

According to the Healthcare Providers & Services industry distribution chart, Imaging Biometrics ranks #30 out of 633 companies for Beneish M-Score. This places Imaging Biometrics in the top 5% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Beneish M-Score for a Healthcare Providers & Services company?

A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Beneish M-Score mean?

A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Imaging Biometrics and its competitors. Imaging Biometrics's current Beneish M-Score is -4.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Imaging Biometrics stock overvalued right now?

Imaging Biometrics (IQAIF) has a current Beneish M-Score of -4.75. The stock's GF Value™ is $0.03, compared to a current price of $0.02 — trading 33.3% below its estimated fair value. The current Beneish M-Score is -4.75. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Beneish M-Score calculated?

Beneish M-Score is calculated from a company's financial statements. For Imaging Biometrics (IQAIF), the current Beneish M-Score is -4.75 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Imaging Biometrics Business Description

Industry Healthcare Healthcare Providers & Services

Comparable Companies AQSE:DXSP LSE:TRLS LSE:FDBK VEEV BTSG ASX:PME TEM HQY TSE:2413 HKSE:02228 HNGE DOCS WAY TXG NSE:IKS PRVA HTFL SZSE:300253 HKSE:01833 NSE:SAGILITY

Other Exchanges IBAI:UK

Address IFC 5, Channel Islands, Saint Helier, JEY, JE1 1ST

Website https://www.imagingbiometrics.com

Imaging Biometrics Ltd formerly, IQ-AI Ltd operates as an investment company. The principal activity of the group is the provision of convenient, cost-effective, and clinical treatments to patients in the field of medical imaging diagnostics, based on technologies. Its geographical segment includes United Kingdom, Switzerland, European Union, and the United States of America and reportable segments are holding company expenses, medical software, Oral GaM and organ-on-a-chip. The company derives a majority of its revenue from the United States of America. It also supplies medical technology solutions and has a neuroimaging product portfolio.